Patents by Inventor Daniel Nieuwlandt

Daniel Nieuwlandt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070166741
    Abstract: The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. In one embodiment, a test sample is contacted with an aptamer that includes a tag and has a specific affinity for a target molecule. An aptamer affinity complex that includes an aptamer bound to its target molecule is allowed to form. If the test sample contains the target molecule, an aptamer affinity complex will generally form in the test sample. The aptamer affinity complex is optionally converted to an aptamer covalent complex that includes an aptamer covalently bound to its target molecule. The aptamer affinity complex (or optional aptamer covalent complex) can then be detected and/or quantified using any of a variety of methods known to one skilled in the art, including using a solid support, using mass spectrometry, and using quantitative polymerase chain reaction (Q-PCR).
    Type: Application
    Filed: January 16, 2007
    Publication date: July 19, 2007
    Applicant: SOMALOGIC, INCORPORATED
    Inventors: James Heil, Daniel Schneider, Daniel Nieuwlandt, Sheri Wilcox, Dominic Zichi, Todd Gander, Bruce Eaton, Larry Gold
  • Publication number: 20070166740
    Abstract: The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. In one embodiment, a test sample is contacted with an aptamer that includes a tag and has a specific affinity for a target molecule. An aptamer affinity complex that includes an aptamer bound to its target molecule is allowed to form. If the test sample contains the target molecule, an aptamer affinity complex will generally form in the test sample. The aptamer affinity complex is optionally converted to an aptamer covalent complex that includes an aptamer covalently bound to its target molecule. The aptamer affinity complex (or optional aptamer covalent complex) can then be detected and/or quantified using any of a variety of methods known to one skilled in the art, including using a solid support, using mass spectrometry, and using quantitative polymerase chain reaction (Q-PCR).
    Type: Application
    Filed: January 16, 2007
    Publication date: July 19, 2007
    Applicant: SOMALOGIC, INCORPORATED
    Inventors: James Heil, Daniel Schneider, Daniel Nieuwlandt, Sheri Wilcox, Dominic Zichi, Todd Gander, Bruce Eaton, Larry Gold